Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT)

AC. Ruwald, C. Schuger, AJ. Moss, V. Kutyifa, B. Olshansky, H. Greenberg, DS. Cannom, NA. Estes, MH. Ruwald, DT. Huang, H. Klein, S. McNitt, CA. Beck, R. Goldstein, MW. Brown, J. Kautzner, M. Shoda, D. Wilber, W. Zareba, JP. Daubert,

. 2014 ; 7 (5) : 785-92. (Arrhythmia and electrophysiology)

Language English Country United States

Document type Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc15014095

BACKGROUND: The benefit of novel implantable cardioverter defibrillator (ICD) programming in reducing inappropriate ICD therapy and mortality was demonstrated in Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT). However, the cause of mortality reduction remains incompletely evaluated. We aimed to identify factors associated with mortality, with focus on ICD therapy and programming in the MADIT-RIT population. METHODS AND RESULTS: In MADIT-RIT, 1500 patients with a primary prophylactic indication for ICD or cardiac resynchronization therapy with defibrillator were randomized to 1 of 3 different ICD programming arms: conventional programming (ventricular tachycardia zone ≥170 beats per minute), high-rate programming (ventricular tachycardia zone ≥200 beats per minute), and delayed programming (60-second delay before therapy ≥170 beats per minute). Multivariate Cox models were used to assess the influence of time-dependent appropriate and inappropriate ICD therapy (shock and antitachycardia pacing) and randomized programming arm on all-cause mortality. During an average follow-up of 1.4±0.6 years, 71 of 1500 (5%) patients died: cardiac in 40 patients (56.3%), noncardiac in 23 patients (32.4%), and unknown in 8 patients (11.3%). Appropriate shocks (hazard ratio, 6.32; 95% confidence interval, 3.13-12.75; P<0.001) and inappropriate therapy (hazard ratio, 2.61; 95% confidence interval, 1.28-5.31; P=0.01) were significantly associated with an increased mortality risk. There was no evidence of increased mortality risk in patients who experienced appropriate antitachycardia pacing only (hazard ratio, 1.02; 95% confidence interval, 0.36-2.88; P=0.98). Randomization to conventional programming was identified as an independent predictor of death when compared with patients randomized to high-rate programming (hazard ratio, 2.0; 95% confidence interval, 1.06-3.71; P=0.03). CONCLUSIONS: In MADIT-RIT, appropriate shocks, inappropriate ICD therapy, and randomization to conventional ICD programming were independently associated with an increased mortality risk. Appropriate antitachycardia pacing was not related to an adverse outcome. CLINICAL TRIAL REGISTRATION URL: clinicaltrials.gov Unique identifier: NCT00947310.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15014095
003      
CZ-PrNML
005      
20240311101323.0
007      
ta
008      
150420s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1161/CIRCEP.114.001623 $2 doi
035    __
$a (PubMed)25136077
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Ruwald, Anne-Christine $u From the Heart Research Follow-up Program, University of Rochester Medical Center, NY (A.-C.R., A.J.M., V.K., M.H.R., D.T.H., H.K., S.M., C.A.B., M.W.B., W.Z.); Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark (A.-C.R., M.H.R.); Division of Cardiology, Henry Ford Hospital, Detroit, MI (C.S.); Department of Medicine, University of Iowa Health Care, Iowa City (B.O.); St Luke's and Roosevelt Hospitals, Departments of Medicine and Epidemiology, Columbia University, New York, NY (H.G.); Division of Cardiology, Hospital of the Good Samaritan, Los Angeles, CA (D.S.C.); Cardiology Division, Cedars-Sinai Heart Institute, Los Angeles, CA (D.S.C.); New England Cardiac Arrhythmia Center, Tufts-New England Medical Center, Boston, MA (N.A.M.E.); Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD (R.G.); Cardiology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic (J.K.); Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan (M.S.); Cardiovascular Institute, Loyola University Medical Center, Chicago, IL (D.W.); and Cardiology Division, Department of Medicine, Duke University Medical Center, Durham, NC (J.P.D.).
245    10
$a Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) / $c AC. Ruwald, C. Schuger, AJ. Moss, V. Kutyifa, B. Olshansky, H. Greenberg, DS. Cannom, NA. Estes, MH. Ruwald, DT. Huang, H. Klein, S. McNitt, CA. Beck, R. Goldstein, MW. Brown, J. Kautzner, M. Shoda, D. Wilber, W. Zareba, JP. Daubert,
520    9_
$a BACKGROUND: The benefit of novel implantable cardioverter defibrillator (ICD) programming in reducing inappropriate ICD therapy and mortality was demonstrated in Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT). However, the cause of mortality reduction remains incompletely evaluated. We aimed to identify factors associated with mortality, with focus on ICD therapy and programming in the MADIT-RIT population. METHODS AND RESULTS: In MADIT-RIT, 1500 patients with a primary prophylactic indication for ICD or cardiac resynchronization therapy with defibrillator were randomized to 1 of 3 different ICD programming arms: conventional programming (ventricular tachycardia zone ≥170 beats per minute), high-rate programming (ventricular tachycardia zone ≥200 beats per minute), and delayed programming (60-second delay before therapy ≥170 beats per minute). Multivariate Cox models were used to assess the influence of time-dependent appropriate and inappropriate ICD therapy (shock and antitachycardia pacing) and randomized programming arm on all-cause mortality. During an average follow-up of 1.4±0.6 years, 71 of 1500 (5%) patients died: cardiac in 40 patients (56.3%), noncardiac in 23 patients (32.4%), and unknown in 8 patients (11.3%). Appropriate shocks (hazard ratio, 6.32; 95% confidence interval, 3.13-12.75; P<0.001) and inappropriate therapy (hazard ratio, 2.61; 95% confidence interval, 1.28-5.31; P=0.01) were significantly associated with an increased mortality risk. There was no evidence of increased mortality risk in patients who experienced appropriate antitachycardia pacing only (hazard ratio, 1.02; 95% confidence interval, 0.36-2.88; P=0.98). Randomization to conventional programming was identified as an independent predictor of death when compared with patients randomized to high-rate programming (hazard ratio, 2.0; 95% confidence interval, 1.06-3.71; P=0.03). CONCLUSIONS: In MADIT-RIT, appropriate shocks, inappropriate ICD therapy, and randomization to conventional ICD programming were independently associated with an increased mortality risk. Appropriate antitachycardia pacing was not related to an adverse outcome. CLINICAL TRIAL REGISTRATION URL: clinicaltrials.gov Unique identifier: NCT00947310.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a rozdělení chí kvadrát $7 D016009
650    12
$a defibrilátory implantabilní $7 D017147
650    _2
$a elektrická defibrilace $x škodlivé účinky $x přístrojové vybavení $x mortalita $7 D004554
650    _2
$a srdeční frekvence $7 D006339
650    _2
$a lidé $7 D006801
650    _2
$a Kaplanův-Meierův odhad $7 D053208
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a multivariační analýza $7 D015999
650    _2
$a proporcionální rizikové modely $7 D016016
650    12
$a protézy - design $7 D011474
650    12
$a selhání protézy $7 D011475
650    _2
$a rizikové faktory $7 D012307
650    _2
$a komorová tachykardie $x diagnóza $x mortalita $x patofyziologie $x terapie $7 D017180
650    _2
$a časové faktory $7 D013997
650    _2
$a výsledek terapie $7 D016896
651    _2
$a Kanada $x epidemiologie $7 D002170
651    _2
$a Evropa $x epidemiologie $7 D005060
651    _2
$a Izrael $x epidemiologie $7 D007557
651    _2
$a Japonsko $x epidemiologie $7 D007564
651    _2
$a Spojené státy americké $x epidemiologie $7 D014481
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a randomizované kontrolované studie $7 D016449
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Schuger, Claudio $u From the Heart Research Follow-up Program, University of Rochester Medical Center, NY (A.-C.R., A.J.M., V.K., M.H.R., D.T.H., H.K., S.M., C.A.B., M.W.B., W.Z.); Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark (A.-C.R., M.H.R.); Division of Cardiology, Henry Ford Hospital, Detroit, MI (C.S.); Department of Medicine, University of Iowa Health Care, Iowa City (B.O.); St Luke's and Roosevelt Hospitals, Departments of Medicine and Epidemiology, Columbia University, New York, NY (H.G.); Division of Cardiology, Hospital of the Good Samaritan, Los Angeles, CA (D.S.C.); Cardiology Division, Cedars-Sinai Heart Institute, Los Angeles, CA (D.S.C.); New England Cardiac Arrhythmia Center, Tufts-New England Medical Center, Boston, MA (N.A.M.E.); Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD (R.G.); Cardiology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic (J.K.); Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan (M.S.); Cardiovascular Institute, Loyola University Medical Center, Chicago, IL (D.W.); and Cardiology Division, Department of Medicine, Duke University Medical Center, Durham, NC (J.P.D.).
700    1_
$a Moss, Arthur J., $u From the Heart Research Follow-up Program, University of Rochester Medical Center, NY (A.-C.R., A.J.M., V.K., M.H.R., D.T.H., H.K., S.M., C.A.B., M.W.B., W.Z.); Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark (A.-C.R., M.H.R.); Division of Cardiology, Henry Ford Hospital, Detroit, MI (C.S.); Department of Medicine, University of Iowa Health Care, Iowa City (B.O.); St Luke's and Roosevelt Hospitals, Departments of Medicine and Epidemiology, Columbia University, New York, NY (H.G.); Division of Cardiology, Hospital of the Good Samaritan, Los Angeles, CA (D.S.C.); Cardiology Division, Cedars-Sinai Heart Institute, Los Angeles, CA (D.S.C.); New England Cardiac Arrhythmia Center, Tufts-New England Medical Center, Boston, MA (N.A.M.E.); Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD (R.G.); Cardiology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic (J.K.); Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan (M.S.); Cardiovascular Institute, Loyola University Medical Center, Chicago, IL (D.W.); and Cardiology Division, Department of Medicine, Duke University Medical Center, Durham, NC (J.P.D.). $d 1914-2004 $7 uk2007404259
700    1_
$a Kutyifa, Valentina $u From the Heart Research Follow-up Program, University of Rochester Medical Center, NY (A.-C.R., A.J.M., V.K., M.H.R., D.T.H., H.K., S.M., C.A.B., M.W.B., W.Z.); Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark (A.-C.R., M.H.R.); Division of Cardiology, Henry Ford Hospital, Detroit, MI (C.S.); Department of Medicine, University of Iowa Health Care, Iowa City (B.O.); St Luke's and Roosevelt Hospitals, Departments of Medicine and Epidemiology, Columbia University, New York, NY (H.G.); Division of Cardiology, Hospital of the Good Samaritan, Los Angeles, CA (D.S.C.); Cardiology Division, Cedars-Sinai Heart Institute, Los Angeles, CA (D.S.C.); New England Cardiac Arrhythmia Center, Tufts-New England Medical Center, Boston, MA (N.A.M.E.); Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD (R.G.); Cardiology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic (J.K.); Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan (M.S.); Cardiovascular Institute, Loyola University Medical Center, Chicago, IL (D.W.); and Cardiology Division, Department of Medicine, Duke University Medical Center, Durham, NC (J.P.D.).
700    1_
$a Olshansky, Brian $u From the Heart Research Follow-up Program, University of Rochester Medical Center, NY (A.-C.R., A.J.M., V.K., M.H.R., D.T.H., H.K., S.M., C.A.B., M.W.B., W.Z.); Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark (A.-C.R., M.H.R.); Division of Cardiology, Henry Ford Hospital, Detroit, MI (C.S.); Department of Medicine, University of Iowa Health Care, Iowa City (B.O.); St Luke's and Roosevelt Hospitals, Departments of Medicine and Epidemiology, Columbia University, New York, NY (H.G.); Division of Cardiology, Hospital of the Good Samaritan, Los Angeles, CA (D.S.C.); Cardiology Division, Cedars-Sinai Heart Institute, Los Angeles, CA (D.S.C.); New England Cardiac Arrhythmia Center, Tufts-New England Medical Center, Boston, MA (N.A.M.E.); Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD (R.G.); Cardiology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic (J.K.); Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan (M.S.); Cardiovascular Institute, Loyola University Medical Center, Chicago, IL (D.W.); and Cardiology Division, Department of Medicine, Duke University Medical Center, Durham, NC (J.P.D.).
700    1_
$a Greenberg, Henry $u From the Heart Research Follow-up Program, University of Rochester Medical Center, NY (A.-C.R., A.J.M., V.K., M.H.R., D.T.H., H.K., S.M., C.A.B., M.W.B., W.Z.); Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark (A.-C.R., M.H.R.); Division of Cardiology, Henry Ford Hospital, Detroit, MI (C.S.); Department of Medicine, University of Iowa Health Care, Iowa City (B.O.); St Luke's and Roosevelt Hospitals, Departments of Medicine and Epidemiology, Columbia University, New York, NY (H.G.); Division of Cardiology, Hospital of the Good Samaritan, Los Angeles, CA (D.S.C.); Cardiology Division, Cedars-Sinai Heart Institute, Los Angeles, CA (D.S.C.); New England Cardiac Arrhythmia Center, Tufts-New England Medical Center, Boston, MA (N.A.M.E.); Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD (R.G.); Cardiology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic (J.K.); Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan (M.S.); Cardiovascular Institute, Loyola University Medical Center, Chicago, IL (D.W.); and Cardiology Division, Department of Medicine, Duke University Medical Center, Durham, NC (J.P.D.).
700    1_
$a Cannom, David S $u From the Heart Research Follow-up Program, University of Rochester Medical Center, NY (A.-C.R., A.J.M., V.K., M.H.R., D.T.H., H.K., S.M., C.A.B., M.W.B., W.Z.); Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark (A.-C.R., M.H.R.); Division of Cardiology, Henry Ford Hospital, Detroit, MI (C.S.); Department of Medicine, University of Iowa Health Care, Iowa City (B.O.); St Luke's and Roosevelt Hospitals, Departments of Medicine and Epidemiology, Columbia University, New York, NY (H.G.); Division of Cardiology, Hospital of the Good Samaritan, Los Angeles, CA (D.S.C.); Cardiology Division, Cedars-Sinai Heart Institute, Los Angeles, CA (D.S.C.); New England Cardiac Arrhythmia Center, Tufts-New England Medical Center, Boston, MA (N.A.M.E.); Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD (R.G.); Cardiology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic (J.K.); Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan (M.S.); Cardiovascular Institute, Loyola University Medical Center, Chicago, IL (D.W.); and Cardiology Division, Department of Medicine, Duke University Medical Center, Durham, NC (J.P.D.).
700    1_
$a Estes, N A Mark $u From the Heart Research Follow-up Program, University of Rochester Medical Center, NY (A.-C.R., A.J.M., V.K., M.H.R., D.T.H., H.K., S.M., C.A.B., M.W.B., W.Z.); Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark (A.-C.R., M.H.R.); Division of Cardiology, Henry Ford Hospital, Detroit, MI (C.S.); Department of Medicine, University of Iowa Health Care, Iowa City (B.O.); St Luke's and Roosevelt Hospitals, Departments of Medicine and Epidemiology, Columbia University, New York, NY (H.G.); Division of Cardiology, Hospital of the Good Samaritan, Los Angeles, CA (D.S.C.); Cardiology Division, Cedars-Sinai Heart Institute, Los Angeles, CA (D.S.C.); New England Cardiac Arrhythmia Center, Tufts-New England Medical Center, Boston, MA (N.A.M.E.); Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD (R.G.); Cardiology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic (J.K.); Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan (M.S.); Cardiovascular Institute, Loyola University Medical Center, Chicago, IL (D.W.); and Cardiology Division, Department of Medicine, Duke University Medical Center, Durham, NC (J.P.D.).
700    1_
$a Ruwald, Martin H $u From the Heart Research Follow-up Program, University of Rochester Medical Center, NY (A.-C.R., A.J.M., V.K., M.H.R., D.T.H., H.K., S.M., C.A.B., M.W.B., W.Z.); Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark (A.-C.R., M.H.R.); Division of Cardiology, Henry Ford Hospital, Detroit, MI (C.S.); Department of Medicine, University of Iowa Health Care, Iowa City (B.O.); St Luke's and Roosevelt Hospitals, Departments of Medicine and Epidemiology, Columbia University, New York, NY (H.G.); Division of Cardiology, Hospital of the Good Samaritan, Los Angeles, CA (D.S.C.); Cardiology Division, Cedars-Sinai Heart Institute, Los Angeles, CA (D.S.C.); New England Cardiac Arrhythmia Center, Tufts-New England Medical Center, Boston, MA (N.A.M.E.); Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD (R.G.); Cardiology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic (J.K.); Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan (M.S.); Cardiovascular Institute, Loyola University Medical Center, Chicago, IL (D.W.); and Cardiology Division, Department of Medicine, Duke University Medical Center, Durham, NC (J.P.D.).
700    1_
$a Huang, David T $u From the Heart Research Follow-up Program, University of Rochester Medical Center, NY (A.-C.R., A.J.M., V.K., M.H.R., D.T.H., H.K., S.M., C.A.B., M.W.B., W.Z.); Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark (A.-C.R., M.H.R.); Division of Cardiology, Henry Ford Hospital, Detroit, MI (C.S.); Department of Medicine, University of Iowa Health Care, Iowa City (B.O.); St Luke's and Roosevelt Hospitals, Departments of Medicine and Epidemiology, Columbia University, New York, NY (H.G.); Division of Cardiology, Hospital of the Good Samaritan, Los Angeles, CA (D.S.C.); Cardiology Division, Cedars-Sinai Heart Institute, Los Angeles, CA (D.S.C.); New England Cardiac Arrhythmia Center, Tufts-New England Medical Center, Boston, MA (N.A.M.E.); Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD (R.G.); Cardiology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic (J.K.); Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan (M.S.); Cardiovascular Institute, Loyola University Medical Center, Chicago, IL (D.W.); and Cardiology Division, Department of Medicine, Duke University Medical Center, Durham, NC (J.P.D.).
700    1_
$a Klein, Helmut $u From the Heart Research Follow-up Program, University of Rochester Medical Center, NY (A.-C.R., A.J.M., V.K., M.H.R., D.T.H., H.K., S.M., C.A.B., M.W.B., W.Z.); Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark (A.-C.R., M.H.R.); Division of Cardiology, Henry Ford Hospital, Detroit, MI (C.S.); Department of Medicine, University of Iowa Health Care, Iowa City (B.O.); St Luke's and Roosevelt Hospitals, Departments of Medicine and Epidemiology, Columbia University, New York, NY (H.G.); Division of Cardiology, Hospital of the Good Samaritan, Los Angeles, CA (D.S.C.); Cardiology Division, Cedars-Sinai Heart Institute, Los Angeles, CA (D.S.C.); New England Cardiac Arrhythmia Center, Tufts-New England Medical Center, Boston, MA (N.A.M.E.); Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD (R.G.); Cardiology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic (J.K.); Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan (M.S.); Cardiovascular Institute, Loyola University Medical Center, Chicago, IL (D.W.); and Cardiology Division, Department of Medicine, Duke University Medical Center, Durham, NC (J.P.D.).
700    1_
$a McNitt, Scott $u From the Heart Research Follow-up Program, University of Rochester Medical Center, NY (A.-C.R., A.J.M., V.K., M.H.R., D.T.H., H.K., S.M., C.A.B., M.W.B., W.Z.); Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark (A.-C.R., M.H.R.); Division of Cardiology, Henry Ford Hospital, Detroit, MI (C.S.); Department of Medicine, University of Iowa Health Care, Iowa City (B.O.); St Luke's and Roosevelt Hospitals, Departments of Medicine and Epidemiology, Columbia University, New York, NY (H.G.); Division of Cardiology, Hospital of the Good Samaritan, Los Angeles, CA (D.S.C.); Cardiology Division, Cedars-Sinai Heart Institute, Los Angeles, CA (D.S.C.); New England Cardiac Arrhythmia Center, Tufts-New England Medical Center, Boston, MA (N.A.M.E.); Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD (R.G.); Cardiology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic (J.K.); Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan (M.S.); Cardiovascular Institute, Loyola University Medical Center, Chicago, IL (D.W.); and Cardiology Division, Department of Medicine, Duke University Medical Center, Durham, NC (J.P.D.).
700    1_
$a Beck, Christopher A $u From the Heart Research Follow-up Program, University of Rochester Medical Center, NY (A.-C.R., A.J.M., V.K., M.H.R., D.T.H., H.K., S.M., C.A.B., M.W.B., W.Z.); Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark (A.-C.R., M.H.R.); Division of Cardiology, Henry Ford Hospital, Detroit, MI (C.S.); Department of Medicine, University of Iowa Health Care, Iowa City (B.O.); St Luke's and Roosevelt Hospitals, Departments of Medicine and Epidemiology, Columbia University, New York, NY (H.G.); Division of Cardiology, Hospital of the Good Samaritan, Los Angeles, CA (D.S.C.); Cardiology Division, Cedars-Sinai Heart Institute, Los Angeles, CA (D.S.C.); New England Cardiac Arrhythmia Center, Tufts-New England Medical Center, Boston, MA (N.A.M.E.); Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD (R.G.); Cardiology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic (J.K.); Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan (M.S.); Cardiovascular Institute, Loyola University Medical Center, Chicago, IL (D.W.); and Cardiology Division, Department of Medicine, Duke University Medical Center, Durham, NC (J.P.D.).
700    1_
$a Goldstein, Robert $u From the Heart Research Follow-up Program, University of Rochester Medical Center, NY (A.-C.R., A.J.M., V.K., M.H.R., D.T.H., H.K., S.M., C.A.B., M.W.B., W.Z.); Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark (A.-C.R., M.H.R.); Division of Cardiology, Henry Ford Hospital, Detroit, MI (C.S.); Department of Medicine, University of Iowa Health Care, Iowa City (B.O.); St Luke's and Roosevelt Hospitals, Departments of Medicine and Epidemiology, Columbia University, New York, NY (H.G.); Division of Cardiology, Hospital of the Good Samaritan, Los Angeles, CA (D.S.C.); Cardiology Division, Cedars-Sinai Heart Institute, Los Angeles, CA (D.S.C.); New England Cardiac Arrhythmia Center, Tufts-New England Medical Center, Boston, MA (N.A.M.E.); Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD (R.G.); Cardiology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic (J.K.); Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan (M.S.); Cardiovascular Institute, Loyola University Medical Center, Chicago, IL (D.W.); and Cardiology Division, Department of Medicine, Duke University Medical Center, Durham, NC (J.P.D.).
700    1_
$a Brown, Mary W $u From the Heart Research Follow-up Program, University of Rochester Medical Center, NY (A.-C.R., A.J.M., V.K., M.H.R., D.T.H., H.K., S.M., C.A.B., M.W.B., W.Z.); Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark (A.-C.R., M.H.R.); Division of Cardiology, Henry Ford Hospital, Detroit, MI (C.S.); Department of Medicine, University of Iowa Health Care, Iowa City (B.O.); St Luke's and Roosevelt Hospitals, Departments of Medicine and Epidemiology, Columbia University, New York, NY (H.G.); Division of Cardiology, Hospital of the Good Samaritan, Los Angeles, CA (D.S.C.); Cardiology Division, Cedars-Sinai Heart Institute, Los Angeles, CA (D.S.C.); New England Cardiac Arrhythmia Center, Tufts-New England Medical Center, Boston, MA (N.A.M.E.); Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD (R.G.); Cardiology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic (J.K.); Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan (M.S.); Cardiovascular Institute, Loyola University Medical Center, Chicago, IL (D.W.); and Cardiology Division, Department of Medicine, Duke University Medical Center, Durham, NC (J.P.D.).
700    1_
$a Kautzner, Josef $u From the Heart Research Follow-up Program, University of Rochester Medical Center, NY (A.-C.R., A.J.M., V.K., M.H.R., D.T.H., H.K., S.M., C.A.B., M.W.B., W.Z.); Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark (A.-C.R., M.H.R.); Division of Cardiology, Henry Ford Hospital, Detroit, MI (C.S.); Department of Medicine, University of Iowa Health Care, Iowa City (B.O.); St Luke's and Roosevelt Hospitals, Departments of Medicine and Epidemiology, Columbia University, New York, NY (H.G.); Division of Cardiology, Hospital of the Good Samaritan, Los Angeles, CA (D.S.C.); Cardiology Division, Cedars-Sinai Heart Institute, Los Angeles, CA (D.S.C.); New England Cardiac Arrhythmia Center, Tufts-New England Medical Center, Boston, MA (N.A.M.E.); Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD (R.G.); Cardiology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic (J.K.); Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan (M.S.); Cardiovascular Institute, Loyola University Medical Center, Chicago, IL (D.W.); and Cardiology Division, Department of Medicine, Duke University Medical Center, Durham, NC (J.P.D.).
700    1_
$a Shoda, Morio $u From the Heart Research Follow-up Program, University of Rochester Medical Center, NY (A.-C.R., A.J.M., V.K., M.H.R., D.T.H., H.K., S.M., C.A.B., M.W.B., W.Z.); Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark (A.-C.R., M.H.R.); Division of Cardiology, Henry Ford Hospital, Detroit, MI (C.S.); Department of Medicine, University of Iowa Health Care, Iowa City (B.O.); St Luke's and Roosevelt Hospitals, Departments of Medicine and Epidemiology, Columbia University, New York, NY (H.G.); Division of Cardiology, Hospital of the Good Samaritan, Los Angeles, CA (D.S.C.); Cardiology Division, Cedars-Sinai Heart Institute, Los Angeles, CA (D.S.C.); New England Cardiac Arrhythmia Center, Tufts-New England Medical Center, Boston, MA (N.A.M.E.); Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD (R.G.); Cardiology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic (J.K.); Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan (M.S.); Cardiovascular Institute, Loyola University Medical Center, Chicago, IL (D.W.); and Cardiology Division, Department of Medicine, Duke University Medical Center, Durham, NC (J.P.D.).
700    1_
$a Wilber, David J. $u From the Heart Research Follow-up Program, University of Rochester Medical Center, NY (A.-C.R., A.J.M., V.K., M.H.R., D.T.H., H.K., S.M., C.A.B., M.W.B., W.Z.); Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark (A.-C.R., M.H.R.); Division of Cardiology, Henry Ford Hospital, Detroit, MI (C.S.); Department of Medicine, University of Iowa Health Care, Iowa City (B.O.); St Luke's and Roosevelt Hospitals, Departments of Medicine and Epidemiology, Columbia University, New York, NY (H.G.); Division of Cardiology, Hospital of the Good Samaritan, Los Angeles, CA (D.S.C.); Cardiology Division, Cedars-Sinai Heart Institute, Los Angeles, CA (D.S.C.); New England Cardiac Arrhythmia Center, Tufts-New England Medical Center, Boston, MA (N.A.M.E.); Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD (R.G.); Cardiology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic (J.K.); Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan (M.S.); Cardiovascular Institute, Loyola University Medical Center, Chicago, IL (D.W.); and Cardiology Division, Department of Medicine, Duke University Medical Center, Durham, NC (J.P.D.). $7 xx0314920
700    1_
$a Zareba, Wojciech $u From the Heart Research Follow-up Program, University of Rochester Medical Center, NY (A.-C.R., A.J.M., V.K., M.H.R., D.T.H., H.K., S.M., C.A.B., M.W.B., W.Z.); Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark (A.-C.R., M.H.R.); Division of Cardiology, Henry Ford Hospital, Detroit, MI (C.S.); Department of Medicine, University of Iowa Health Care, Iowa City (B.O.); St Luke's and Roosevelt Hospitals, Departments of Medicine and Epidemiology, Columbia University, New York, NY (H.G.); Division of Cardiology, Hospital of the Good Samaritan, Los Angeles, CA (D.S.C.); Cardiology Division, Cedars-Sinai Heart Institute, Los Angeles, CA (D.S.C.); New England Cardiac Arrhythmia Center, Tufts-New England Medical Center, Boston, MA (N.A.M.E.); Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD (R.G.); Cardiology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic (J.K.); Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan (M.S.); Cardiovascular Institute, Loyola University Medical Center, Chicago, IL (D.W.); and Cardiology Division, Department of Medicine, Duke University Medical Center, Durham, NC (J.P.D.).
700    1_
$a Daubert, James P $u From the Heart Research Follow-up Program, University of Rochester Medical Center, NY (A.-C.R., A.J.M., V.K., M.H.R., D.T.H., H.K., S.M., C.A.B., M.W.B., W.Z.); Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark (A.-C.R., M.H.R.); Division of Cardiology, Henry Ford Hospital, Detroit, MI (C.S.); Department of Medicine, University of Iowa Health Care, Iowa City (B.O.); St Luke's and Roosevelt Hospitals, Departments of Medicine and Epidemiology, Columbia University, New York, NY (H.G.); Division of Cardiology, Hospital of the Good Samaritan, Los Angeles, CA (D.S.C.); Cardiology Division, Cedars-Sinai Heart Institute, Los Angeles, CA (D.S.C.); New England Cardiac Arrhythmia Center, Tufts-New England Medical Center, Boston, MA (N.A.M.E.); Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD (R.G.); Cardiology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic (J.K.); Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan (M.S.); Cardiovascular Institute, Loyola University Medical Center, Chicago, IL (D.W.); and Cardiology Division, Department of Medicine, Duke University Medical Center, Durham, NC (J.P.D.). daube001@duke.edu.
773    0_
$w MED00159578 $t Circulation. Arrhythmia and electrophysiology. Arrhythmia and electrophysiology $x 1941-3084 $g Roč. 7, č. 5 (2014), s. 785-92
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25136077 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150420 $b ABA008
991    __
$a 20240311101321 $b ABA008
999    __
$a ok $b bmc $g 1071676 $s 896973
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 7 $c 5 $d 785-92 $i 1941-3084 $m Circulation. Arrhythmia and electrophysiology $n Circ Arrhythm Electrophysiol $x MED00159578 $o Arrhythmia and electrophysiology
LZP    __
$a Pubmed-20150420

Find record

Citation metrics

Archiving options